In a report released today, John Ransom from Raymond James maintained a Buy rating on UnitedHealth (UNH - Research Report), with a price target of $635.00. The company's shares closed yesterday at $512.08.According to TipRanks, Ransom is a 5-star analyst with an average return of 9.8% and a 57.88% success rate. Ransom covers the Healthcare sector, focusing on stocks such as HCA Healthcare, Tenet Healthcare, and Acadia Healthcare.UnitedHealth has an analyst consensus of Strong Buy, with a price target consensus of $593.54, implying a 15.91% upside from current levels. In a report released on September 8, Deutsche Bank also maintained a Buy rating on the stock with a $569.
https://www.tipranks.com/news/blurbs/raymond-james-sticks-to-their-buy-rating-for-unitedhealth-unh?utm_source=advfn.com&utm_medium=referral
UnitedHealth (NYSE:UNH)
Gráfica de Acción Histórica
De Nov 2022 a Dic 2022 Haga Click aquí para más Gráficas UnitedHealth.
UnitedHealth (NYSE:UNH)
Gráfica de Acción Histórica
De Dic 2021 a Dic 2022 Haga Click aquí para más Gráficas UnitedHealth.